Eli Lilly invites you to an engaging session on emerging diagnostic tools for Alzheimer's disease (AD), featuring an international panel of leading primary care and neurology experts, Prof. Sebastian Palmqvist, Dr. Ziad Nasreddine, Prof. Suzanne E. Schindler, and Dr.

Stephanie Daly. The experts will discuss the role of digital cognitive assessments in streamlining the detection of cognitive impairment, the use of blood tests for faster and more accurate AD diagnosis and determining eligibility for amyloid-targeting therapies, and general practitioner perspectives on incorporating blood tests into AD diagnosis. 1-3 Designed around an interactive live Q&A, the session offers an opportunity to engage directly with the international faculty, ask questions, and gain insights into the evolving approaches to AD diagnosis. Join the experts on November 19 , 2026 , from 5:30 PM to 6:30 PM IST for…